Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of miR-122 Serum Level and IFN-λ3 Genotypes in Patients with Chronic HCV and HCV-Infected Liver Transplant Candidate.

MicroRNA (Shariqah, United Arab Emirates) - 1 Jan 2021

Moayedi Javad, Hashempour Tayebeh, Musavi Zahra, Arefian Ehsan, Naderi Mahmood, Heidari Mohamad Reza, Dehghani Behzad, Hasanshahi Zahra, Merat Shahin

Abstract excerpt

BACKGROUND: Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are the most common markers of liver damage, but serum level interpretation can be complicated. In hepatocytes, microRNA-122 (miR-122) is the most abundant miRs and its high expression in the serum is a characteristic of liver disease. OBJECTIVE: We aimed to compare the circulatory level of miR-122 in patients with Chronic Hepatitis C...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genotype
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Hepatitis C, Chronic

Share to Interferons

Share to Liver Transplantation

Share to MicroRNAs

Source

Identifiers

PMID: 33334303
DOI: 10.2174/2211536609666201217101414

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of miR-122 Serum Level and IFN-λ3 Genotypes in Patients with Chronic HCV and HCV-Infected Liver Transplant Candidate.PMID 33334303Read ↗

Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C.Semantic proximity Read ↗

Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis.Semantic proximity Read ↗

Severity of hepatitis C virus (genotype-3) infection positively correlates with circulating microRNA-122 in patients sera.Semantic proximity Read ↗

Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3.Semantic proximity Read ↗

Circulating miR-122 as a Potential Biomarker of Liver DiseaseSemantic proximity Read ↗

Circulating microRNA-122 in HCV Cirrhotic Patients with High Frequency of Genotype 3Semantic proximity Read ↗

Parallel expression profiling of hepatic and serum microRNA-122 associated with clinical features and treatment responses in chronic hepatitis C patientsSemantic proximity Read ↗

Circulating microRNA-122 in HCV cirrhotic patients with high frequency of genotype 3.Semantic proximity Read ↗

MicroRNA-122a as a non-invasive biomarker for HCV genotype 4-related hepatocellular carcinoma in Egyptian patientsSemantic proximity Read ↗

MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection.Semantic proximity Read ↗

Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C.Semantic proximity Read ↗

Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.